Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity
Alexandra Moisand1,2, Mathilde Madéry1,2, Thomas Boyer1,2
1CNRS UMR 5164, ImmunoConcEpT, Biological and Medical Sciences Department, University of Bordeaux, 33076 Bordeaux, France.
Abstract:
Breast cancers regroup many heterogeneous diseases unevenly responding to currently available therapies. Approximately 70-80% of breast cancers express hormone (estrogen or progesterone) receptors. Patients with these hormone-dependent breast malignancies benefit from therapies targeting endocrine pathways. Nevertheless, metastatic disease remains a major challenge despite available treatments, and relapses frequently ensue. By improving patient survival and quality of life, cancer immunotherapies have sparked considerable enthusiasm and hope in the last decade but have led to only limited success in breast cancers. In addition, only patients with hormone-independent breast cancers seem to benefit from these immune-based approaches. The present review examines and discusses the current literature related to the role of hormone receptor signaling (specifically, an estrogen receptor) and the impact of its modulation on the sensitivity of breast cancer cells to the effector mechanisms of anti-tumor immune responses and on the capability of breast cancers to escape from protective anti-cancer immunity. Future research prospects related to the possibility of promoting the efficacy of immune-based interventions using hormone therapy agents are considered.
Insights
Hormone receptor signaling in breast cancer impacts immune response. Modulating hormone pathways may enhance immunotherapy effectiveness for hormone-dependent breast cancers.
Area of Science:
- Oncology
- Immunology
- Endocrinology
Background:
- Breast cancer comprises diverse subtypes with variable treatment responses.
- Hormone receptors (estrogen/progesterone) are present in 70-80% of breast cancers, influencing treatment strategies.
- While immunotherapies show promise, their efficacy in breast cancer, particularly hormone-dependent types, remains limited.
Purpose of the Study:
- To review the literature on estrogen receptor signaling in breast cancer.
- To examine how hormone receptor modulation affects anti-tumor immunity and immune evasion.
- To explore combining hormone therapy with immunotherapy for improved breast cancer treatment.
Main Methods:
- Literature review of studies on hormone receptor signaling and breast cancer immunity.
- Analysis of estrogen receptor's role in immune sensitivity and escape mechanisms.
- Discussion of potential therapeutic strategies combining hormone and immune therapies.
Main Results:
- Estrogen receptor signaling influences breast cancer cell sensitivity to anti-tumor immune responses.
- Hormone-dependent breast cancers may exhibit distinct immune evasion strategies.
- Current immunotherapies are less effective in hormone-dependent breast cancers.
Conclusions:
- Estrogen receptor signaling is a critical factor in breast cancer's interaction with the immune system.
- Targeting hormone pathways could potentially enhance the efficacy of cancer immunotherapies.
- Further research is needed to optimize combination therapies for hormone-dependent breast cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Signal Transduction: Overview
Typically, signal transduction involves three...
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...

